Antiproliferative Effect of Trifolium Pratens L. Extract in Human Breast Cancer Cells

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.: Global cancer statistics, 2012. CA Cancer J Clin 65(2), 87–108, 2015.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL, and van‘t Veer LJ: Breast cancer metastasis: markers and models. Nat Rev Cancer 5, 591–602, 2005.
   PubMed Web of Science ®Google Scholar
• WHO: Fact Sheet No. 297 (Updated 25 February 2015).
   Google Scholar
• Chang M: Tamoxifen resistance in breast cancer. Biomol Ther (Seoul) 20(3), 256–267, 2012.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Saxena N, Sengupta K, and Banerjee SK: 17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway. Biochem Biophys Res Commun 300, 209–215, 2003.
   PubMed Web of Science ®Google Scholar
• Bijnsdorp IV, Giovannetti E, and Peters GJ: Analysis of drug interactions. Methods Mol Biol 731, 421–434, 2011.
   PubMedGoogle Scholar
• Kinghorn AD, Chin YW, and Swanson SM: Discovery of natural product anticancer agents from biodiverse organisms. Curr Opin Drug Discov Devel 12(2), 189–196, 2009.
   PubMedGoogle Scholar
• Bhanot A, Sharma R, and Noolvi MN: Natural sources as potential anti-cancer agents: a review. Int J Phytomedicine 3, 09–26, 2011.
   Google Scholar
• Vlaisavljevic S, Kaurinovic B, Popovic M, Djurendic-Brenesel M, Vasiljevic B, et al.: Trifolium pratense L. as a potential natural antioxidant. Molecules 19, 713–725, 2014.
   PubMed Web of Science ®Google Scholar
• Booth NL, Overk CR, Yao P, Totura S, Deng Y, et al.: Seasonal variation of red clover (Trifolium pratense L., Fabaceae) isoflavones and estrogenic activity. J Agric Food Chem 54(4), 1277–1282, 2006.
   PubMed Web of Science ®Google Scholar
• Khazaei M, Pazhouhi M, and Khazaei S: Evaluation of hydro-alcoholic extract of Trifolium Pratens L. for its anti-cancer potential on U87MG Cell line. Cell J 20(3), 412–421, 2018.
   PubMed Web of Science ®Google Scholar
• Johnstone RW, Ruefli AA, and Lowe SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153–164, 2002.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kanzawa T, Sawaya R, and Kondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5, 726–734, 2005.
   PubMed Web of Science ®Google Scholar
• Yousefi S and Simon HU: Autophagy in cancer and chemotherapy. Results Probl Cell Differ 49, 183–190, 2009.
   PubMedGoogle Scholar
• Basu A and Haldar S: The relationship between BcI2, Bax and P53: consequences for cell cycle progression and cell death. Mol Hum Reprod 4(12), 1099–1109, 1998.
   PubMed Web of Science ®Google Scholar
• Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, et al.: Increased Bax/Bcl-2 ratio up-regulates Caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo 21(1), 123–132, 2007.
   PubMed Web of Science ®Google Scholar
• Nikoletopoulou V, Markaki M, Palikaras K, and Tavernarakis N: Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta (BBA) - Mol Cell Res 1833(12), 3448–3459, 2013.
   PubMed Web of Science ®Google Scholar
• Scherz-Shouval R, Weidberg H, Gonen C, Wilder S, Elazar Z, et al.: P53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc Natl Acad Sci U S A 107(43), 18511–18516, 2010.
   PubMed Web of Science ®Google Scholar
• Liu C, Xu P, Chen D, Fan X, Xu Y, et al.: Roles of autophagy-related genes Beclin-1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia. Biomed Rep 1(6), 855–860, 2013.
   PubMedGoogle Scholar
• Weidberg H, Shvets E, and Elazar Z: Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 80, 125–156, 2011.
   PubMed Web of Science ®Google Scholar
• Booth NL, Overk CR, Yao P, Burdette JE, Nikolic D, et al.: The chemical and biologic profile of a red clover (Trifolium pratense L.) Phase II clinical extract. J Altern Complement Med 12(2), 133–139, 2006.
   PubMed Web of Science ®Google Scholar
• Kaurinovic B, Popovic M, Vlaisavljevic S, Schwartsova H, and Vojinovic-Miloradov M: Antioxidant Profile of Trifolium pratense L. Molecules 17, 11156–11172, 2012.
   PubMed Web of Science ®Google Scholar
• Amawi H, Ashby CR Jr, and Tiwari AK1: Cancer chemoprevention through dietary flavonoids: what's limiting? Chin J Cancer 36(1), 50, 2017.
   PubMedGoogle Scholar
• Mahajan P, Gnana Oli R, Jachak SM, Bharate SB, and Chaudhuri B: Antioxidant and antiproliferative activity of indigocarpan, a pterocarpan from Indigofera aspalathoides. J Pharm Pharmacol 68(10), 1331–1339, 2016.
   PubMed Web of Science ®Google Scholar
• Thakur A, Singla R, and Jaitak V: Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies. Eur J Med Chem 101, 476–495, 2015.
   PubMed Web of Science ®Google Scholar
• Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, and Joshi V: Nitric oxide and cancer: a review. World J Surg Oncol 11, 118, 2013.
   PubMed Web of Science ®Google Scholar
• Strober W: Trypan blue exclusion test of cell viability. Curr Protoc Immunol. Appendix 3, Appendix 3B, 2001. doi: 10.1002/0471142735.ima03bs21.
   Google Scholar
• van Meerloo J, Kaspers GJL, and Cloos J: Cell sensitivity assays: the MTT assay. In: Cancer Cell Culture (Methods and Protocols), Cree I (ed.). New York: Humana Press, 2011, Vol 731. pp. 237–245.
   Google Scholar
• Liu K, Liu PC, Liu R, and Wu X: Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. Med Sci Monit Basic Res 21, 15–20, 2015.
   PubMed Web of Science ®Google Scholar
• Chou TC: Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70, 440–446, 2010.
   PubMed Web of Science ®Google Scholar